Races and ethnic groups in DM

Endocrine Function: C.B. is a significantly overweight, 48-year-old woman from the Winnebago Indian tribe who had high blood sugar and cholesterol levels three years ago but did not follow up with a clinical diagnostic work-up. She had participated in the state’s annual health screening program and noticed that her fasting blood sugar was 141 and her cholesterol was 225. However, she felt “perfectly fine at the time” and could not afford any more medications. Except for many “female infections,” she has felt fine until recently. Today, she presents to the Indian Hospital general practitioner complaining that her left foot has been weak and numb for nearly three weeks and that the foot is difficult to flex. She denies any other weakness or numbness at this time. However, she reports that she has been very thirsty lately and gets up more often at night to urinate. She has attributed these symptoms to the extremely warm weather and drinking more water to keep her hydrated. She has gained a total of 65 pounds since her last pregnancy 14 years ago, 15 pounds in the last 6 months alone. Case Study Questions In which race and ethnic groups is DM more prevalent? Based on C.B.'s clinical manifestations, please compile the signs and symptoms that she is exhibiting that are compatible with the Diabetes Mellitus Type 2 diagnosis. If C.B. develops bacterial pneumonia on her right lower lobe, how would you expect her Glycemia values to be? Explain and support your answer. What would be the best initial therapy non-pharmacologic and pharmacologic to be recommended to C.B?

Sample Solution

     

Case Study: C.B. and Potential Diabetes Mellitus Type 2

Prevalence of Diabetes Mellitus in Different Racial and Ethnic Groups:

While diabetes mellitus (DM) can affect anyone, some groups have a higher prevalence compared to others. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), certain racial and ethnic groups in the United States have a higher risk:

  • Hispanic/Latino: 12.8%
  • Black (non-Hispanic): 12.2%
  • American Indian/Alaska Native: 11.5%
  • Non-Hispanic Asian: 8.0%
  • Non-Hispanic White: 7.4%

These statistics highlight the importance of considering C.B.'s Winnebago Indian heritage as a potential risk factor for developing DM.

Clinical Manifestations Suggestive of Diabetes Mellitus Type 2 in C.B.:

  • Elevated fasting blood sugar (141 mg/dL): Normal fasting blood sugar is below 100 mg/dL.
  • High cholesterol (225 mg/dL): Desirable LDL cholesterol level is below 100 mg/dL.
  • Increased thirst and urination: Classic symptoms of uncontrolled diabetes due to excess glucose in the blood.
  • Foot weakness and numbness: Potential diabetic neuropathy, a complication of chronic hyperglycemia.
  • Recent weight gain: May contribute to insulin resistance,
 

Full Answer Section

     
  •  a hallmark of type 2 diabetes.

These signs and symptoms, coupled with C.B.'s family history of diabetes and lack of follow-up after previous abnormal results, raise strong suspicion for a diagnosis of type 2 diabetes. Further investigations like HbA1c and oral glucose tolerance test are needed for confirmation.

Impact of Bacterial Pneumonia on Glycemia:

Bacterial pneumonia can trigger stress hormones like cortisol and glucagon, leading to increased blood sugar levels (hyperglycemia) in diabetic patients. This phenomenon is called stress-induced hyperglycemia. Therefore, C.B.'s glycemic control is likely to worsen if she develops pneumonia, requiring close monitoring and adjustments to her diabetes management plan.

Recommended Initial Therapy for C.B.:

Non-pharmacologic:

  • Lifestyle modifications:
    • Healthy diet: Emphasize fruits, vegetables, whole grains, and lean protein while limiting processed foods and sugary drinks.
    • Regular physical activity: Aim for at least 150 minutes of moderate-intensity exercise per week.
    • Weight management: Losing even 5-10% of body weight can significantly improve insulin sensitivity.

Pharmacologic:

  • The specific medication choice depends on individual factors like severity, comorbidities, and response to therapy. Options may include:
    • Metformin: First-line medication for type 2 diabetes, promoting insulin sensitivity and reducing glucose production.
    • Sulfonylureas: Stimulate insulin secretion from the pancreas.
    • DPP-4 inhibitors: Enhance insulin secretion and reduce glucagon production.
    • SGLT2 inhibitors: Help the kidneys eliminate excess glucose through urine.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional for diagnosis and treatment of any medical condition.

It's important to note that C.B.'s case requires a comprehensive evaluation by a healthcare professional to develop a personalized treatment plan considering her specific medical history, cultural background, and individual needs.

IS IT YOUR FIRST TIME HERE? WELCOME

USE COUPON "11OFF" AND GET 11% OFF YOUR ORDERS